U.S. In Vitro Diagnostics Market: Emerging Trends and Future Growth

The rising incidences of chronic and infectious diseases, increasing awareness of health and fitness, as well as major technological advancements are key factors driving the IVD market in the U.S. However, the lack of sufficient budget and reimbursement for novel diagnostic tests are restraining market …

Roche Diagnostics Limited (Switzerland) and Danaher Corporation (U.S.) Dominate the U.S. In Vitro Diagnostics Market

On the basis of technology, the U.S. IVD market is broadly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, and others. Among these, the immunoassays/immunochemistry segment accounted for the largest share of the U.S. IVD market in 2014. The ability of …